Proud to fund research initiatives to help kids with cancer.

Understanding the genetic basis of chemotherapy-induced cardiomyopathy
Understanding the genetic basis of chemotherapy-induced cardiomyopathy
Institute: The Murdoch Children’s Research Institute
Recipient: Dr Rachel Conyers
Funding: $590,877 July 2018 to June 2022
IntReALL-HR
IntReALL-HR
Institute: ANZCHOG
Recipient: Associate Professor Tamas Revesz
Funding: $416,422 July 2018 to June 2022
MicroRNA drugs for the treatment of neuroblastoma
MicroRNA drugs for the treatment of neuroblastoma
Institute: Garvan Institute of Medical Research
Recipient: Associate Professor Alexander Swarbrick
Funding: $308,270 July 2018 to June 2021
The NORTH Trial
The NORTH Trial
Institute: ANZCHOG
Recipient: Dr Paul Wood
Funding: $61,420 July 2018 to June 2021
Personalised Medicine: Zero Childhood Cancer
Personalised Medicine: Zero Childhood Cancer
Institute: Children’s Cancer Institute
Recipient: Professor Michelle Haber
Funding: $1,167,250 July 2014 to June 2021
New therapies for incurable paediatric brain tumours
New therapies for incurable paediatric brain tumours
Institute: The Institute of Molecular Bioscience
Recipient: Professor Brandon Wainwright
Funding: $224,936 July 2018 to June 2020
Combinational therapeutics in high-risk infant acute lymphoblastic leukaemia
Combinational therapeutics in high-risk infant acute lymphoblastic leukaemia
Institute: Telethon Kids Institute
Recipient: Dr Rishi Kotecha
Funding: $180,000 February 2018 to January 2020
Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia – a novel epigenetic
Reversing glucocorticoid resistance in paediatric acute lymphoblastic leukaemia – a novel epigenetic
Institute: Children’s Cancer Institute
Recipient: Professor Richard Lock
Funding: $103,571 July 2017 to June 2020
Targeting FACT to inhibit MYCN-driven transcription in neuroblastoma
Targeting FACT to inhibit MYCN-driven transcription in neuroblastoma
Institute: UNSW Australia
Recipient: Dr Daniel Carter
Funding: $296,428 July 2016 to June 2020
Synthetic retinoid therapy for diffuse intrinsic pontine glioma
Synthetic retinoid therapy for diffuse intrinsic pontine glioma
Institute: Children’s Cancer Institute
Recipient: Associate Professor David Ziegler
Funding: $200,000 July 2016 to June 2020
International clinical trials support
International clinical trials support
Recipient: Australian and New Zealand Children’s Haematology/Oncology Group
Funding: $325,000 July 2015 to June 2020
Using targeted chemotherapies to reduce intensity of radiotherapy in medulloblastoma
Using targeted chemotherapies to reduce intensity of radiotherapy in medulloblastoma
Institute: Telethon Kids Institute
Recipient: Dr Nick Gottardo
Funding: $129,179 July 2018 to June 2019
New state-wide Children’s and Adolescent/Young Adult Cancer Clinical Trials Unit
New state-wide Children’s and Adolescent/Young Adult Cancer Clinical Trials Unit
Institute: Royal Hobart Hospital
Recipient: Associate Professor John Heath
Funding: $140,000 July 2017 to June 2019
Ready, Steady, School
Ready, Steady, School
Institute: UNSW Australia
Recipient: Dr Joanna Fardell
Funding: $298,162 July 2016 to June 2019
Pre-clinical development of novel immune therapy for paediatric cancers
Pre-clinical development of novel immune therapy for paediatric cancers
Institute: Sydney Children's Hospital
Recipient: Dr Alla Dolnikov
Funding: $160,000 July 2016 to June 2019
Together we can end childhood cancer.
The only way to improve outcomes for children with cancer is through advances in medical research. Every day and every donation takes us closer to a cure.
Select your donation details
Please enter the amount you would like to donate

The Kids' Cancer Project is an ACNC Registered Charity 
ABN 13 061 138 181 | CFN 10581